“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: Starpharma
Starpharma is an Australian biotechnology company with two decades of experience in advancing dendrimer technologies from the lab to the patient.
Starpharma — 3 videos in collection
Starpharma is an Australian biotechnology company focused on applying its proprietary Dendrimer Enhanced Product (DEP) platform to targeted oncology therapies. Dendrimers are precise nanoscale molecules that can be designed to carry drugs or radioactive payloads to tumour cells. Starpharma’s portfolio spans a lead radiopharmaceutical asset, clinical-stage oncology candidates, partnered programmes and marketed consumer health products.
We highlight the key points of Starpharma’s investment story.
For further details, please refer to our latest research on Starpharma.
Get access to the very latest content matched to your personal investment style.